{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T02:36:32Z","timestamp":1790476592291,"version":"4.1.0"},"reference-count":75,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K23HL151671"],"award-info":[{"award-number":["K23HL151671"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal.chestnet.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["CHEST"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.chest.2024.08.046","type":"journal-article","created":{"date-parts":[[2024,9,7]],"date-time":"2024-09-07T03:20:17Z","timestamp":1725679217000},"page":"374-386","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Diagnosis and Prevention of Invasive Fungal Infections in the Immunocompromised Host"],"prefix":"10.1016","volume":"167","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1951-0636","authenticated-orcid":false,"given":"Abdul","family":"Wahab","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9596-7104","authenticated-orcid":false,"given":"David","family":"Sanborn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6581-3956","authenticated-orcid":false,"given":"Paschalis","family":"Vergidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5248-0227","authenticated-orcid":false,"given":"Raymund","family":"Razonable","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1889-2524","authenticated-orcid":false,"given":"Hemang","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly M.","family":"Pennington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.chest.2024.08.046_bib1","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1016\/j.jaci.2017.04.010","article-title":"Etiology of epithelial barrier dysfunction in patients with type 2 inflammatory diseases","volume":"139","author":"Schleimer","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.chest.2024.08.046_bib2","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1183\/09031936.02.00229102","article-title":"Allergy and immunity to fungal infections and colonization","volume":"19","author":"Crameri","year":"2002","journal-title":"Eur Respir J"},{"issue":"11","key":"10.1016\/j.chest.2024.08.046_bib3","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1038\/ni.2987","article-title":"Neutrophils sense microbe size and selectively release neutrophil extracellular traps in response to large pathogens","volume":"15","author":"Branzk","year":"2014","journal-title":"Nat Immunol"},{"issue":"9","key":"10.1016\/j.chest.2024.08.046_bib4","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1038\/ni.2369","article-title":"C-type lectin receptors orchestrate antifungal immunity","volume":"13","author":"Hardison","year":"2012","journal-title":"Nat Immunol"},{"issue":"4","key":"10.1016\/j.chest.2024.08.046_bib5","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/nri2939","article-title":"Immunity to fungal infections","volume":"11","author":"Romani","year":"2011","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"10.1016\/j.chest.2024.08.046_bib6","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/S1369-5274(02)00337-5","article-title":"Induced humoral immunity and vaccination against major human fungal pathogens","volume":"5","author":"Casadevall","year":"2002","journal-title":"Curr Opin Microbiol"},{"issue":"4","key":"10.1016\/j.chest.2024.08.046_bib7","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1097\/TP.0000000000004871","article-title":"Risk factors for early fungal disease in solid organ transplant recipients: a systematic review and meta-analysis","volume":"108","author":"Pennington","year":"2024","journal-title":"Transplantation"},{"issue":"3","key":"10.1016\/j.chest.2024.08.046_bib8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0194430","article-title":"TNF-alpha blockade impairs in\u00a0vitro tuberculous granuloma formation and down modulate Th1, Th17 and Treg cytokines","volume":"13","author":"Silva","year":"2018","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.chest.2024.08.046_bib9","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0025-6196(11)60839-2","article-title":"Fungal infections complicating tumor necrosis factor alpha blockade therapy","volume":"83","author":"Tsiodras","year":"2008","journal-title":"Mayo Clin Proc"},{"issue":"4","key":"10.1016\/j.chest.2024.08.046_bib10","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0153247","article-title":"Intra-abdominal candidiasis: the importance of early source control and antifungal treatment","volume":"11","author":"Vergidis","year":"2016","journal-title":"PLoS One"},{"issue":"Suppl 1","key":"10.1016\/j.chest.2024.08.046_bib11","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.1093\/ofid\/ofy358","article-title":"Twenty years of the SENTRY Antifungal Surveillance Program: results for Candida species from 1997-2016","volume":"6","author":"Pfaller","year":"2019","journal-title":"Open Forum Infect Dis"},{"issue":"6","key":"10.1016\/j.chest.2024.08.046_bib12","doi-asserted-by":"crossref","first-page":"432","DOI":"10.7326\/M19-2205","article-title":"Candida auris: an emerging antimicrobial resistance threat","volume":"171","author":"Vallabhaneni","year":"2019","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1016\/j.chest.2024.08.046_bib13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0017046","article-title":"From attachment to damage: defined genes of Candida albicans mediate adhesion, invasion and damage during interaction with oral epithelial cells","volume":"6","author":"Wachtler","year":"2011","journal-title":"PLoS One"},{"issue":"pt 3","key":"10.1016\/j.chest.2024.08.046_bib14","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1099\/mic.0.033530-0","article-title":"Candida albicans biofilm formation in a new in\u00a0vivo rat model","volume":"156","author":"Ricicova","year":"2010","journal-title":"Microbiology (Reading)"},{"issue":"5","key":"10.1016\/j.chest.2024.08.046_bib15","first-page":"535","article-title":"Chronic disseminated candidiasis in patients with hematologic malignancies. Clinical features and outcome of 29 episodes","volume":"87","author":"Pagano","year":"2002","journal-title":"Haematologica"},{"issue":"4","key":"10.1016\/j.chest.2024.08.046_bib16","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofac045","article-title":"The incidence of ocular complications in candidemic patients and implications for the practice of routine eye exams","volume":"9","author":"Hillenbrand","year":"2022","journal-title":"Open Forum Infect Dis"},{"issue":"11","key":"10.1016\/j.chest.2024.08.046_bib17","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1093\/cid\/cix1095","article-title":"Detecting Infections Rapidly and Easily for Candidemia Trial, Part 2 (DIRECT2): a prospective, multicenter study of the T2Candida Panel","volume":"66","author":"Clancy","year":"2018","journal-title":"Clin Infect Dis"},{"issue":"7","key":"10.1016\/j.chest.2024.08.046_bib18","article-title":"(1\u21923)-beta-D-glucan testing for the detection of invasive fungal infections in immunocompromised or critically ill people","volume":"7","author":"White","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"10.1016\/j.chest.2024.08.046_bib19","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1093\/cid\/ciu959","article-title":"T2 magnetic resonance assay for the rapid diagnosis of candidemia in whole blood: a clinical trial","volume":"60","author":"Mylonakis","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.chest.2024.08.046_bib20","series-title":"Cryptococcus: From Human Pathogen to Model Yeast","author":"Heitman","year":"2010"},{"issue":"4","key":"10.1016\/j.chest.2024.08.046_bib21","doi-asserted-by":"crossref","DOI":"10.1093\/femsyr\/fow045","article-title":"Environmental distribution of Cryptococcus neoformans and C. gattii around the Mediterranean basin","volume":"16","author":"Cogliati","year":"2016","journal-title":"FEMS Yeast Res"},{"issue":"8","key":"10.1016\/j.chest.2024.08.046_bib22","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/S1473-3099(17)30243-8","article-title":"Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis","volume":"17","author":"Rajasingham","year":"2017","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"10.1016\/j.chest.2024.08.046_bib23","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/j.1567-1364.2006.00071.x","article-title":"The molecular basis for the immunogenicity of Cryptococcus neoformans mannoproteins","volume":"6","author":"Levitz","year":"2006","journal-title":"FEMS Yeast Res"},{"key":"10.1016\/j.chest.2024.08.046_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/bs.adgen.2020.02.001","article-title":"Pathogen and host genetics underpinning cryptococcal disease","volume":"105","author":"Coelho","year":"2020","journal-title":"Adv Genet"},{"issue":"2","key":"10.1016\/j.chest.2024.08.046_bib25","doi-asserted-by":"crossref","first-page":"251","DOI":"10.3201\/eid1602.090900","article-title":"Epidemiology of Cryptococcus gattii, British Columbia, Canada, 1999\u20132007","volume":"16","author":"Galanis","year":"2010","journal-title":"Emerg Infect Dis"},{"issue":"1","key":"10.1016\/j.chest.2024.08.046_bib26","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1093\/mmy\/myx010","article-title":"Examination of cryptococcal glucuronoxylomannan antigen in bronchoalveolar lavage fluid for diagnosing pulmonary cryptococcosis in HIV-negative patients","volume":"56","author":"Oshima","year":"2018","journal-title":"Med Mycol"},{"issue":"1","key":"10.1016\/j.chest.2024.08.046_bib27","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/TP.0b013e3181bcda41","article-title":"Identifying predictors of central nervous system disease in solid organ transplant recipients with cryptococcosis","volume":"89","author":"Osawa","year":"2010","journal-title":"Transplantation"},{"issue":"12","key":"10.1016\/j.chest.2024.08.046_bib28","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1086\/599039","article-title":"Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry","volume":"48","author":"Horn","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"10","key":"10.1016\/j.chest.2024.08.046_bib29","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/j.healun.2018.06.008","article-title":"Clinical risk factors for invasive aspergillosis in lung transplant recipients: results of an international cohort study","volume":"37","author":"Aguilar","year":"2018","journal-title":"J\u00a0Heart Lung Transplant"},{"issue":"5","key":"10.1016\/j.chest.2024.08.046_bib30","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1164\/rccm.201906-1185ST","article-title":"Microbiological laboratory testing in the diagnosis of fungal infections in pulmonary and critical care practice. An official American Thoracic Society Clinical Practice Guideline","volume":"200","author":"Hage","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"10.1016\/j.chest.2024.08.046_bib31","first-page":"427","article-title":"Invasive pulmonary aspergillosis following bone marrow transplantation: risk factors and diagnostic aspect","volume":"32","author":"Soubani","year":"2002","journal-title":"Haematologia (Budap)"},{"issue":"1-3","key":"10.1016\/j.chest.2024.08.046_bib32","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0141-8130(02)00046-6","article-title":"Preparation and characterization of molecular weight fractions of guar galactomannans using acid and enzymatic hydrolysis","volume":"31","author":"Cheng","year":"2002","journal-title":"Int J Biol Macromol"},{"issue":"42","key":"10.1016\/j.chest.2024.08.046_bib33","doi-asserted-by":"crossref","first-page":"26724","DOI":"10.18632\/oncotarget.25477","article-title":"Breakthrough invasive aspergillosis and diagnostic accuracy of serum galactomannan enzyme immune assay during acute myeloid leukemia induction chemotherapy with posaconazole prophylaxis","volume":"9","author":"Calmettes","year":"2018","journal-title":"Oncotarget"},{"issue":"10","key":"10.1016\/j.chest.2024.08.046_bib34","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD009551.pub2","article-title":"Polymerase chain reaction blood tests for the diagnosis of invasive aspergillosis in immunocompromised people","author":"Cruciani","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"issue":"11","key":"10.1016\/j.chest.2024.08.046_bib35","doi-asserted-by":"crossref","first-page":"3652","DOI":"10.1128\/JCM.00942-12","article-title":"Diagnostic accuracy of PCR alone compared to galactomannan in bronchoalveolar lavage fluid for diagnosis of invasive pulmonary aspergillosis: a systematic review","volume":"50","author":"Avni","year":"2012","journal-title":"J\u00a0Clin Microbiol"},{"issue":"1","key":"10.1016\/j.chest.2024.08.046_bib36","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.cmi.2018.07.011","article-title":"The epidemiology and clinical manifestations of mucormycosis: a systematic review and meta-analysis of case reports","volume":"25","author":"Jeong","year":"2019","journal-title":"Clin Microbiol Infect"},{"issue":"2","key":"10.1016\/j.chest.2024.08.046_bib37","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1128\/AAC.01136-07","article-title":"Zygomycetes hyphae trigger an early, robust proinflammatory response in human polymorphonuclear neutrophils through toll-like receptor 2 induction but display relative resistance to oxidative damage","volume":"52","author":"Chamilos","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"issue":"7","key":"10.1016\/j.chest.2024.08.046_bib38","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1055\/s-2000-4647","article-title":"Computed tomographic appearance of pulmonary mucormycosis","volume":"172","author":"Vogl","year":"2000","journal-title":"Rofo"},{"issue":"6","key":"10.1016\/j.chest.2024.08.046_bib39","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1128\/JCM.00256-11","article-title":"Molecular methods to improve diagnosis and identification of mucormycosis","volume":"49","author":"Hammond","year":"2011","journal-title":"J\u00a0Clin Microbiol"},{"issue":"5","key":"10.1016\/j.chest.2024.08.046_bib40","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1093\/cid\/ciab1066","article-title":"Evaluation of serum mucorales polymerase chain reaction (PCR) for the diagnosis of mucormycoses: the MODIMUCOR prospective trial","volume":"75","author":"Millon","year":"2022","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.chest.2024.08.046_bib41","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0087784","article-title":"Earlier diagnosis of invasive fusariosis with Aspergillus serum galactomannan testing","volume":"9","author":"Nucci","year":"2014","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.chest.2024.08.046_bib42","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1111\/1469-0691.12409","article-title":"Improvement in the outcome of invasive fusariosis in the last decade","volume":"20","author":"Nucci","year":"2014","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"10.1016\/j.chest.2024.08.046_bib43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/1040841X.2018.1514366","article-title":"Prognostic factors in 264 adults with invasive Scedosporium spp. and Lomentospora prolificans infection reported in the literature and FungiScope","volume":"45","author":"Seidel","year":"2019","journal-title":"Crit Rev Microbiol"},{"issue":"12","key":"10.1016\/j.chest.2024.08.046_bib44","doi-asserted-by":"crossref","first-page":"8271","DOI":"10.4049\/jimmunol.175.12.8271","article-title":"CD8\u00a0T cell-mediated lung damage in response to the extracellular pathogen pneumocystis is dependent on MHC class I expression by radiation-resistant lung cells","volume":"175","author":"Meissner","year":"2005","journal-title":"J\u00a0Immunol"},{"issue":"2","key":"10.1016\/j.chest.2024.08.046_bib45","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.mayocp.2020.07.029","article-title":"Host factors and outcomes in hospitalizations for Pneumocystis jirovecii pneumonia in the United States","volume":"96","author":"Kanj","year":"2021","journal-title":"Mayo Clin Proc"},{"issue":"1","key":"10.1016\/j.chest.2024.08.046_bib46","doi-asserted-by":"crossref","first-page":"R28","DOI":"10.1186\/cc6806","article-title":"Critical care management and outcome of severe Pneumocystis pneumonia in patients with and without HIV infection","volume":"12","author":"Monnet","year":"2008","journal-title":"Crit Care"},{"issue":"35","key":"10.1016\/j.chest.2024.08.046_bib47","doi-asserted-by":"crossref","first-page":"59729","DOI":"10.18632\/oncotarget.19927","article-title":"Risk factors for mortality from pneumocystis carinii pneumonia (PCP) in non-HIV patients: a meta-analysis","volume":"8","author":"Liu","year":"2017","journal-title":"Oncotarget"},{"issue":"3","key":"10.1016\/j.chest.2024.08.046_bib48","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1378\/chest.08-1309","article-title":"Polymerase chain reaction for diagnosing pneumocystis pneumonia in non-HIV immunocompromised patients with pulmonary infiltrates","volume":"135","author":"Azoulay","year":"2009","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.chest.2024.08.046_bib49","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1469-0691.2011.03760.x","article-title":"Accuracy of \u03b2-D-glucan for the diagnosis of Pneumocystis jirovecii pneumonia: a meta-analysis","volume":"19","author":"Karageorgopoulos","year":"2013","journal-title":"Clin Microbiol Infect"},{"issue":"3","key":"10.1016\/j.chest.2024.08.046_bib50","doi-asserted-by":"crossref","first-page":"370","DOI":"10.3201\/eid2203.151117","article-title":"Epidemiology of histoplasmosis outbreaks, United States, 1938-2013","volume":"22","author":"Benedict","year":"2016","journal-title":"Emerg Infect Dis"},{"issue":"3","key":"10.1016\/j.chest.2024.08.046_bib51","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1093\/cid\/civ299","article-title":"Histoplasmosis complicating tumor necrosis factor-alpha blocker therapy: a retrospective analysis of 98 cases","volume":"61","author":"Vergidis","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.chest.2024.08.046_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.simyco.2020.02.001","article-title":"The global epidemiology of emerging Histoplasma species in recent years","volume":"97","author":"Rodrigues","year":"2020","journal-title":"Stud Mycol"},{"issue":"1","key":"10.1016\/j.chest.2024.08.046_bib53","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1055\/s-0039-1698429","article-title":"Current concepts in the epidemiology, diagnosis, and management of histoplasmosis syndromes","volume":"41","author":"Azar","year":"2020","journal-title":"Semin Respir Crit Care Med"},{"issue":"7","key":"10.1016\/j.chest.2024.08.046_bib54","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1093\/cid\/ciac882","article-title":"The geographic distribution of dimorphic mycoses in the United States for the modern era","volume":"76","author":"Mazi","year":"2023","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.chest.2024.08.046_bib55","first-page":"40","article-title":"Outcomes with severe pulmonary coccidioidomycosis and respiratory failure in the United States","volume":"8","author":"Rush","year":"2023","journal-title":"J\u00a0Assoc Med Microbiol Infect Dis Can"},{"key":"10.1016\/j.chest.2024.08.046_bib56","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.mmcr.2016.09.002","article-title":"Evidence of delayed dissemination or re-infection with blastomyces in two immunocompetent hosts","volume":"13","author":"Anderson","year":"2016","journal-title":"Med Mycol Case Rep"},{"issue":"5","key":"10.1016\/j.chest.2024.08.046_bib57","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1378\/chest.15-0289","article-title":"Blastomycosis in Indiana: clinical and epidemiologic patterns of disease gleaned from a multicenter retrospective study","volume":"148","author":"Azar","year":"2015","journal-title":"Chest"},{"issue":"6","key":"10.1016\/j.chest.2024.08.046_bib58","doi-asserted-by":"crossref","first-page":"e112","DOI":"10.1093\/cid\/ciw360","article-title":"2016 Infectious Diseases Society of America (IDSA) clinical practice guideline for the treatment of coccidioidomycosis","volume":"63","author":"Galgiani","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.chest.2024.08.046_bib59","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1017\/ice.2019.303","article-title":"Pathogens causing central-line-associated bloodstream infections in acute-care hospitals-United States, 2011-2017","volume":"41","author":"Novosad","year":"2020","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"6","key":"10.1016\/j.chest.2024.08.046_bib60","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.3201\/eid2606.191570","article-title":"Cannabis use and fungal infections in a commercially insured population, United States, 2016","volume":"26","author":"Benedict","year":"2020","journal-title":"Emerg Infect Dis"},{"issue":"10","key":"10.1016\/j.chest.2024.08.046_bib61","doi-asserted-by":"crossref","DOI":"10.1093\/mmy\/myad103","article-title":"Environmental monitoring for filamentous fungal pathogens in hematopoietic cell transplant units","volume":"61","author":"Marek","year":"2023","journal-title":"Med Mycol"},{"issue":"7","key":"10.1016\/j.chest.2024.08.046_bib62","doi-asserted-by":"crossref","first-page":"e1302","DOI":"10.1093\/cid\/ciaa1189","article-title":"Immunosuppressive agents and infectious risk in transplantation: managing the \"net state of immunosuppression\"","volume":"73","author":"Roberts","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"34","key":"10.1016\/j.chest.2024.08.046_bib63","doi-asserted-by":"crossref","first-page":"5471","DOI":"10.1200\/JCO.2007.12.3851","article-title":"Antifungal prophylaxis in cancer patients after chemotherapy or hematopoietic stem-cell transplantation: systematic review and meta-analysis","volume":"25","author":"Robenshtok","year":"2007","journal-title":"J\u00a0Clin Oncol"},{"issue":"10","key":"10.1016\/j.chest.2024.08.046_bib64","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1038\/bjc.2012.147","article-title":"Mould-active compared with fluconazole prophylaxis to prevent invasive fungal diseases in cancer patients receiving chemotherapy or haematopoietic stem-cell transplantation: a systematic review and meta-analysis of randomised controlled trials","volume":"106","author":"Ethier","year":"2012","journal-title":"Br J Cancer"},{"issue":"1","key":"10.1016\/j.chest.2024.08.046_bib65","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jac\/dkt329","article-title":"Mixed treatment comparison of prophylaxis against invasive fungal infections in neutropenic patients receiving therapy for haematological malignancies: a systematic review","volume":"69","author":"Pechlivanoglou","year":"2014","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"10","key":"10.1016\/j.chest.2024.08.046_bib66","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.17652","article-title":"Comparison of antifungal prophylaxis drugs in patients with hematological disease or undergoing hematopoietic stem cell transplantation: a systematic review and network meta-analysis","volume":"3","author":"Wang","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"15","key":"10.1016\/j.chest.2024.08.046_bib67","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1007\/s40265-021-01611-0","article-title":"The antifungal pipeline: fosmanogepix, ibrexafungerp, olorofim, opelconazole, and rezafungin","volume":"81","author":"Hoenigl","year":"2021","journal-title":"Drugs"},{"issue":"2","key":"10.1016\/j.chest.2024.08.046_bib68","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3109\/23744235.2015.1100322","article-title":"Antifungal prophylaxis with liposomal amphotericin B and caspofungin in high-risk patients after liver transplantation: impact on fungal infections and immune system","volume":"48","author":"Perrella","year":"2016","journal-title":"Infect Dis (Lond)"},{"issue":"7","key":"10.1016\/j.chest.2024.08.046_bib69","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.13630","article-title":"Antifungal prophylaxis in lung transplant: a survey of United States' transplant centers","volume":"33","author":"Pennington","year":"2019","journal-title":"Clin Transplant"},{"issue":"4","key":"10.1016\/j.chest.2024.08.046_bib70","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/ciw326","article-title":"Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the Infectious Diseases Society of America","volume":"63","author":"Patterson","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"10","key":"10.1016\/j.chest.2024.08.046_bib71","article-title":"Prophylaxis for Pneumocystis pneumonia (PCP) in non-HIV immunocompromised patients","volume":"2014","author":"Stern","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.chest.2024.08.046_bib72","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1186\/s13075-019-1996-6","article-title":"Pneumocystis pneumonia in patients with rheumatic diseases receiving prolonged, non-high-dose steroids-clinical implication of primary prophylaxis using trimethoprim-sulfamethoxazole","volume":"21","author":"Park","year":"2019","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.chest.2024.08.046_bib73","doi-asserted-by":"crossref","first-page":"e23","DOI":"10.1016\/j.ejim.2017.11.014","article-title":"Pneumocystis jirovecii pneumonia in patients treated with rituximab for systemic diseases: report of 11 cases\u00a0and review of the literature","volume":"50","author":"Alexandre","year":"2018","journal-title":"Eur J Intern Med"},{"issue":"7","key":"10.1016\/j.chest.2024.08.046_bib74","first-page":"1186","article-title":"Risk factors for Pneumocystis carinii pneumonia in patients with polymyositis\/dermatomyositis or systemic lupus erythematosus","volume":"23","author":"Kadoya","year":"1996","journal-title":"J\u00a0Rheumatol"},{"issue":"5","key":"10.1016\/j.chest.2024.08.046_bib75","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/j.chest.2021.11.007","article-title":"Primary prophylaxis for Pneumocystis jirovecii pneumonia in patients receiving rituximab","volume":"161","author":"Park","year":"2022","journal-title":"Chest"}],"container-title":["CHEST"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369224051407?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369224051407?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T12:15:00Z","timestamp":1761394500000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369224051407"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":75,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["S0012369224051407"],"URL":"https:\/\/doi.org\/10.1016\/j.chest.2024.08.046","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diagnosis and Prevention of Invasive Fungal Infections in the Immunocompromised Host","name":"articletitle","label":"Article Title"},{"value":"CHEST","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chest.2024.08.046","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 American College of Chest Physicians. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}